Experimental benznidazole encephalopathy: I. Clinical-neurological alterations

Journal of the Neurological Sciences

Volumn 150, Issue 1, 1997, Pages 3-11

  Lucia Leite Flores Vieira, Carmen ^a   Antunes Barreira, Amilton ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Benznidazole; Chagas' disease; Clinical neurological alterations; Experimental encephalopathy

Indexed keywords

BENZNIDAZOLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; APATHY; ARTICLE; ATAXIA; BRAIN DISEASE; CHAGAS DISEASE; CONTROLLED STUDY; DOG; ELECTROENCEPHALOGRAM; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; QUADRIPLEGIA;

ANIMALS; ATAXIA; BRAIN DISEASES; CRANIAL NERVES; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MALE; MOTOR ACTIVITY; NEUROTOXINS; NITROIMIDAZOLES; POSTURE; QUADRIPLEGIA; REFLEX; REFLEX, STRETCH; TRYPANOCIDAL AGENTS;

EID: 0342762072     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(97)05361-6     Document Type: Article

References (23)

1. Arruda, Jr., E.R. (1986) Tratamento específico da doença de Chagas. Tolerância clínica do benzonidazol usado na posologia de 5mg/kg de peso ao dia, durante 30 dias. Rev. Soc. Bras. Med. Trop., 19: 40.
2. Barclay, C.A., Cerisola, J.A., Lugones, H., Ledesma, O., Silva, J.L. and Morizo, G. (1978) Aspectos farmacológicos e resultados terapêuticos do benzonidazol, novo agente quimioterápico para tratamento da infecção de Chagas. La Prensa Argentina, 65: 239-244.
3. Bradley, W.G., Karlsson, I.J. and Rassol, C.G. (1977) Metronidazole neuropathy. Br. Med. J., 1977, 2: 610-611.
4. Braund, K.G., Clinical syndromes in veterinary neurology, 2nd ed. Williams and Wilkins and Mosby-Year Book, Baltimore and Missouri, 1994, pp. 1-34, 52-64, 76-78, 96 and 1-12, 55-68, 70-74, 89-92, 119-121, 251-255, 274-275, 281-285.
5. Coxon, A. and Pallis, C.A. (1976) Metronidazole neuropathy. J Neurol. Neurosurg. Psych., 39: 403-405.
6. Dische, S., Saunders, M.I., Lee, M.E., Adams, G.E., Flockhart, I.R. (1977) Clinical testing of the radiosensitizer Ro-07-0582: experience with multiple doses. Br. J. Cancer, 35: 567-579.
7. Faria, C.R., Souza, S.E.M. and Rassi, A. (1986) Polineuropatia periférica induzida por benzonidazol no tratamento da doença de Chagas. Arq. Neuropsiq., 44(2): 125-129.
8. Favaretto, A.L.V., Antunes-Rodrigues, J., Vieira, C.L.L.F.R. and Lamano-Carvalho, T.L. (1990) Pituitary-testicular axis in benznidazole treated rats. Brazilian J. Med. Biol. Res., 23: 719-722.
9. Ferreira, H.O. (1976) Ensaio terapêutico-clínico com o benzonidazol na doença de Chagas. Rev. Inst. Med. Trop., 18(5): 357-364.
10. Griffin, J.W., Price, D.L., Kuethe, D.O. and Goldberg, A.M. (1980) Neurotoxicity of misonidazole in rats. 1. Neuropathol. Neurotoxicol., 1: 653-666.
11. Kirchhoff, L.V. (1993) American Trypanosomiasis (Chagas' disease) - A Tropical disease now in the United States. New Engl. J. Med., 329(9): 639-644.
12. Kusumi, R.K., Plouffe, J.F., Wyatt, R.H. and Fass, R.J. (1980) Central nervous system toxicity associated with metronidazole therapy. Ann. Int. Med., 93: 380-388.
13. Lamano-Carvalho, T.L., Vieira, C.L.L.F.R., Antunes-Rodrigues, J. and Favaretto A.L.V. (1990) Reversibility of the gonadotoxic effects of benznidazole. Archivos de La Facultad de Medicina de zaragoza., 30: 145-149.
14. Levi, G.C., Amato-Neto, V. and Sant'Anna, I.F.A.B. (1975) Análise de manifestações colaterais devidas ao uso do medicamento Ro 7-1051, nitroimidazólico preconizado para tentativas de tratamento específico da doença de Chagas. Rev. Inst. Med. Trop., 17: 49-54.
15. Mamoli, B., Wessely, P., Kogelnik, H.D., Muller, M. and Rathkolb, O. (1979) Electroneurographic investigations of misonidazole polyneuropathy. Eur. Neurol., 18: 405-414.
16. -Data sheet on Ro 7-1051 et al.Roche Research Department-Data sheet on Ro 7-1051, a new compound for oral treatment of Chagas disease (unpublished).
17. Rogulja, P.R., Kovac, W. and Schmid, H. (1973) Metronidazol-encephalopathie der Ratte. Acta Neuropathol., 25: 36-45.
18. Said, G., Goasguen, J. and Laverdant, C. (1978) Neuropathy in long term treatment with metronidazole. Rev. Neurol., 134: 515-521.
19. Schärer, K. (1972) Selective alteration of Purkinje cells in the dog after oral administration of high doses of nitroimidazole derivatives. Verhandlungen der deutscher Gesellschaft für Pathologie, 56: 407-410.
20. Schipper, H., Beale, F.A., Bush, R.S. and Fryer, C. (1976) Metronidazole as a radiosensitizer. New Engl. J. Med., 295: 901.
21. Stevenson, M.A., Calderwood, S.K and Coleman C.N. (1989) Effects of nitroimidazoles on neuronal cells in vitro. Int. J. Rad. Oncol. Biol. Phys., 16: 1225-1230.
22. Vieira, C.L.L.F., Lamano-Carvalho, T.L., Favaretto, A.L.V., Valença, M.M., Antunes-Rodrigues, J. and Barreira, A.A. (1989) Testes alterations in pubertal benznidazole-treated rats. Brazilian J. Med. Biol. Res., 22: 695-698.
23. . Workshop on guidelines for standarded protocols for the chemotheraphy of Chagas' disease TDR/CHEMCHA/DC WL SHP/ 81.3 and Washington DC, 1981, World Health Organization. Workshop on guidelines for standard protocols for the chemotheraphy of Chagas' disease TDR/CHEMCHA/DC WL SHP/ 81.3, Washington DC, 1981.